LivaNova (LIVN) Net Cash Flow (2015 - 2026)
LivaNova (LIVN) reported Net Cash Flow of -$93.6 million for Q1 2026, down 1149.78% on a YoY basis from $8.9 million in Q1 2025, and down 771.11% sequentially from -$10.7 million in Q4 2025.
LivaNova (LIVN) Net Cash Flow (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Net Cash Flow data on file, last reported at -$93.6 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 1149.78% year-over-year to -$93.6 million; the trailing twelve-month figure through Mar 2026 stood at -$206.8 million (down 270.06% YoY), and the FY2025 full-year result was -$104.2 million, down 167.94% from the prior year.
- Net Cash Flow fell to -$93.6 million in Q1 2026, from -$10.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $235.2 million in Q1 2022 to a low of -$155.0 million in Q2 2025.
- A 5-year average of $19.0 million and a median of $11.4 million in 2023 frame the typical range for Net Cash Flow.
- Across the five-year window, Net Cash Flow surged 18077.59% in 2022 and sank 1149.78% in 2026, its largest moves.
- Tracing LIVN's Net Cash Flow over 5 years: stood at $6.1 million in 2022, then jumped by 504.0% to $36.8 million in 2023, then soared by 75.41% to $64.6 million in 2024, then slumped by 116.65% to -$10.7 million in 2025, then plunged by 771.11% to -$93.6 million in 2026.
- Business Quant data shows LIVN's Net Cash Flow at -$93.6 million in Q1 2026, -$10.7 million in Q4 2025, and $52.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | -93.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -93.61 Mn |
| Mar 31, 2026 | -93.61 Mn |
| Dec 31, 2025 | -10.75 Mn |
| Dec 31, 2025 | -10.75 Mn |
| Sep 30, 2025 | 52.63 Mn |
| Sep 30, 2025 | 52.63 Mn |
| Jun 30, 2025 | -155.03 Mn |
| Jun 30, 2025 | -155.03 Mn |
| Mar 31, 2025 | 8.92 Mn |
| Mar 31, 2025 | 8.92 Mn |
| Dec 31, 2024 | 64.56 Mn |
| Dec 31, 2024 | 64.56 Mn |
| Sep 30, 2024 | 29.19 Mn |
| Sep 30, 2024 | 29.19 Mn |
| Jun 30, 2024 | 18.92 Mn |
| Jun 30, 2024 | 18.92 Mn |
| Mar 31, 2024 | 40.77 Mn |
| Mar 31, 2024 | 40.77 Mn |
| Dec 31, 2023 | 36.80 Mn |
| Dec 31, 2023 | 36.80 Mn |